Skip to main content
. 2023 May 17;63(2):145–152. doi: 10.2169/internalmedicine.1817-23

Table 2.

CLDQ and SF-36 Scores among Patients with AIH.

Zinc supplementation p
Before (n=26) After (n=26)
SF-36
Physical functioning 90.0 (70.0-95.0) 85.0 (70.0-95.0) 0.465
Role physical 93.8 (71.9-100.0) 93.8 (76.6-100.0) 0.566
Bodily pain 84.0 (62.0-100.0) 79.0 (61.3-100.0) 0.655
General health 52.0 (50.0-67.0) 53.5 (45.5-67.0) 0.133
Vitality 71.9 (56.3-79.7) 68.8 (56.3-79.7) 0.095
Social functioning 87.5 (75.0-100.0) 100.0 (75.0-100.0) 0.472
Role emotion 91.7 (77.1-100.0) 100.0 (75.0-100.0) 0.720
Mental Health 75.0 (70.0-88.8) 77.5 (70.0-90.0) 0.646
PCS 47.7 (37.5-51.8) 47.0 (31.6-51.0) 0.055
MCS 54.9 (50.0-56.9) 53.0 (48.0-58.7) 0.319
RCS 49.3 (44.4-56.3) 53.1 (45.2-59.5) 0.895
CLDQ
Overall 6.3 (5.7-6.7) 6.1 (5.5-6.5) 0.643
Abdominal 6.3 (5.7-6.9) 6.2 (5.4-6.7) 0.315
Fatigue 5.6 (5.0-6.2) 5.7 (5.4-6.2) 0.803
Systemic 5.7 (5.2-6.4) 5.8 (5.2-6.2) 0.774
Activity 6.0 (5.4-6.7) 6.0 (5.7-6.7) 0.362
Emotions 5.8 (5.2-6.1) 5.9 (5.5-6.2) 0.401
Worry 5.5 (4.8-6.2) 5.8 (5.1-6.4) 0.017

Data are shown as median (interquartile range). CLDQ: Chronic Liver Disease Questionnaire, SF-36: 36-Item Short Form Survey, AIH: autoimmune hepatitis, PCS: physical component summary, MCS: mental component summary, RCS: role/social component summary